|
1
|
Marotta LL and Polyak K: Cancer stem
cells: a model in the making. Curr Opin Genet Dev. 19:44–50. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bonnet D and Dick JE: Human acute myeloid
leukemia is organized as a hierarchy that originates from a
primitive hematopoietic cell. Nat Med. 3:730–737. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Singh SK, Clarke ID, Terasaki M, et al:
Identification of a cancer stem cell in human brain tumors. Cancer
Res. 63:5821–5828. 2003.PubMed/NCBI
|
|
5
|
Fang D, Nguyen TK, Leishear K, et al: A
tumorigenic subpopulation with stem cell properties in melanomas.
Cancer Res. 65:9328–9337. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Collins AT, Berry PA, Hyde C, Stower MJ
and Maitland NJ: Prospective identification of tumorigenic prostate
cancer stem cells. Cancer Res. 65:10946–10951. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li C, Heidt DG, Dalerba P, et al:
Identification of pancreatic cancer stem cells. Cancer Res.
67:1030–1037. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
O'Brien CA, Pollett A, Gallinger S and
Dick JE: A human colon cancer cell capable of initiating tumour
growth in immunodeficient mice. Nature. 445:106–110. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Baba T, Convery PA, Matsumura N, et al:
Epigenetic regulation of CD133 and tumorigenicity of
CD133+ovarian cancer cells. Oncogene. 28:209–218. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ma S, Chan KW, Hu L, et al: Identification
and characterization of tumorigenic liver cancer stem/progenitor
cells. Gastroenterology. 132:2542–2556. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kim CF, Jackson EL, Woolfenden AE, et al:
Identification of bronchioalveolar stem cells in normal lung and
lung cancer. Cell. 121:823–835. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shmelkov SV, St Clair R, Lyden D and Rafii
S: AC133/CD133/Prominin-1. Int J Biochem Cell Biol. 37:715–719.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Klonisch T, Wiechec E, Hombach-Klonisch S,
et al: Cancer stem cell markers in common cancers - therapeutic
implications. Trends Mol Med. 14:450–460. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Galli R, Binda E, Orfanelli U, et al:
Isolation and characterization of tumorigenic, stem-like neural
precursors from human glioblastoma. Cancer Res. 64:7011–7021. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bao S, Wu Q, McLendon RE, et al: Glioma
stem cells promote radioresistance by preferential activation of
the DNA damage response. Nature. 444:756–760. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Richardson GD, Robson CN, Lang SH, Neal
DE, Maitland NJ and Collins AT: CD133, a novel marker for human
prostatic epithelial stem cells. J Cell Sci. 117:3539–3545. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yin S, Li J, Hu C, Chen X, et al: CD133
positive hepatocellular carcinoma cells possess high capacity for
tumorigenicity. Int J Cancer. 120:1444–1450. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Frank NY, Margaryan A, Huang Y, et al:
ABCG5-mediated doxorubicin transport and chemoresistance in human
malignant melanoma. Cancer Res. 65:4320–4333. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hermann PC, Huber SL, Herrler T, et al:
Distinct populations of cancer stem cells determine tumor growth
and metastatic activity in human pancreatic cancer. Cell Stem Cell.
1:313–323. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tirino V, Desiderio V, d'Aquino R, et al:
Detection and characterization of CD133+cancer stem
cells in human solid tumours. PLoS One. 3:e34692008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang J, Guo LP, Chen LZ, Zeng YX and Lu
SH: Identification of cancer stem cell-like side population cells
in human nasopharyngeal carcinoma cell line. Cancer Res.
67:3716–3724. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang HB, Ren CP, Yang XY, et al:
Identification of label-retaining cells in nasopharyngeal epithelia
and nasopharyngeal carcinoma tissues. Histochem Cell Biol.
127:347–354. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Huang EH, Heidt DG, Li CW and Simeone DM:
Cancer stem cells: a new paradigm for understanding tumor
progression and therapeutic resistance. Surgery. 141:415–419. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Soltysova A, Altanerova V and Altaner C:
Cancer stem cells. Neoplasma. 52:435–440. 2005.
|
|
25
|
Li L and Neaves WB: Normal stem cells and
cancer stem cells: the niche matters. Cancer Res. 66:4553–4557.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Postovit LM, Margaryan NV, Seftor EA, et
al: Human embryonic stem cell microenvironment suppresses the
tumorigenic phenotype of aggressive cancer cells. Proc Natl Acad
Sci USA. 105:4329–4334. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wei XD, Zhou L, Cheng L, Tian J, Jiang JJ
and Maccallum J: In vivo investigation of CD133 as a putative
marker of cancer stem cells in Hep-2 cell line. Head Neck.
31:94–101. 2009. View Article : Google Scholar : PubMed/NCBI
|
